Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real time.
Hear about our venture into the development and manufacturing of viral vector gene therapies and how we are overcoming challenges and maintaining our commitment to our partners.
The success of using viral vectors to deliver a molecular payload into a cell or replace defective genes with functional ones is an inflection point in the future of modern medicine.
Accelerated clinical trial timelines for advanced therapeutics are on the rise. With fast-track status designations, it is increasingly critical for innovators to have efficient and scalable production processes.
This website uses cookies to ensure you get the best experience on our website. Learn more
